Table 1.
ERCC1 Expression | ||||
---|---|---|---|---|
Low | High | p-value | ||
Age (years) | ≤ 55 | 27 (54.0%) | 23 (46.0%) | 0.974 |
> 55 | 22 (53.7%) | 19 (46.3%) | ||
Sex | Male | 25 (49.0%) | 26 (51.0%) | 0.297 |
Female | 24 (60.0%) | 16 (40.0%) | ||
Residence | Shobra | 13 (61.9%) | 8 (38.1%) | 0.556 |
Helwan | 10 (45.5%) | 12 (54.5%) | ||
Others | 26 (54.2%) | 22 (45.8%) | ||
Smoking | Non- or Ex-smoker | 30 (58.8%) | 21 (41.2%) | 0.282 |
Current Smoker | 19 (47.5%) | 21 (52.5%) | ||
Pathology | Epithelioid | 44 (57.1%) | 33 (42.9%) | 0.139 |
Sarcomatoid/biphasic | 5 (35.7%) | 9 (64.3%) | ||
Treatment Protocol | GEM | 20 (55.6%) | 16 (44.4%) | 0.791 |
Alimta | 29 (52.7%) | 26 (47.3%) | ||
Response | Regressive | 24 (68.6%) | 11 (31.4%) | 0.019 |
Progressive | 13 (36.1%) | 23 (63.9%) | ||
Stable | 12 (60.0%) | 8 (40.0%) |